Telix Pharmaceuticals Ltd has released a press release.
Telix Plans U.S. Registered Public Offering and Listing
Filed with ASX ·
Watch Telix Pharmaceuticals' latest callTelix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call6ix hasn’t read this filing yet.
Telix Pharmaceuticals Limited on 6ix
In the deck
Earlier from Telix Pharmaceuticals
- Telix Submits BLA for TLX250-CDx for Kidney Cancer Imaging
- Telix Announces Proposed Acquisition of QSAM Biosciences
- First Patient Dosed in Ph III ProstACT GLOBAL Therapy Study
- Telix Completes Acquisition of Lightpoint Medical
- ProstACT SELECT Study of TLX591 Positive Interim Readout
Later from Telix Pharmaceuticals
- JP Morgan Healthcare Conference and Trading Update
- JP Morgan Healthcare Conference Presentation
- Presentation to Accompany QSAM Acquisition
- Telix Acquires QSAM and its Bone Cancer Targeting Platform
- 2023 Full Year Results Release
Follow Telix Pharmaceuticals into a list and get an email when it puts out news.
Follow Telix Pharmaceuticals